Fingolimod after natalizumab and the risk of short-term relapse. Jokubaitis VG, Li V, Kalincik T, Izquierdo G, Hodgkinson S, Alroughani R, Lechner-Scott J, Lugaresi A, Duquette P, Girard M, et al. Neurology. 2014 Mar 7. PMID: 24610329. Abstract CommentRecommendBookmarkWatch